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Abstract:  Out of the 90 human protein tyrosine kinases, 81 were assayed with short peptides derived from well-
characterized [CDK1(Tyr15), IRS1(Tyr983), and JAK1(Tyr1023)] or generic [polyGlu:Tyr(4:1) and poly-
Glu:Ala:Tyr(1:1:1)] substrates. As expected, the CDK1 peptide is a substrate for all Src family kinases. On the other hand, 
some of the activities are novel and lead to a better understanding of the function of certain kinases. Specifically, the 
CDK1 peptide is a substrate for many of the Eph family members. Interestingly, profiling of nearly all the human protein 
tyrosine kinases revealed a distinct pattern of selectivity towards the CDK1 and IRS1 peptides. 
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INTRODUCTION 
  PTKs are involved in many cell signaling pathways. 
These enzymes represent early key regulators in such func-
tions as cell growth, proliferation, differentiation, secretion, 
and apoptosis [1]. Aberrant protein kinase expression or 
function is a cause or consequence of many human diseases 
like cancer and atherosclerosis. As a result, kinases represent 
very important targets in the development of therapeutics.  
  Protein kinase selectivity is critical for appropriate intra-
cellular signaling. Kinase-substrate interactions are mediated 
via specific interaction sites such as SH2 domains, but also 
by the distinct specificity of the catalytic domain. The use of 
small peptides to investigate kinase specificity and catalysis 
is supported by crystallographic structures of kinase-peptide 
complexes as well as studies with synthetic peptide libraries 
[2,3]. Considering that almost all human PTKs have recently 
become available as purified recombinant enzymes, it has 
become possible to profile peptide substrate activity 
throughout the entire group to possibly reveal novel 
specificities of individual kinases and kinase sub-families. 
Previously, a study was performed on the yeast kinome [4] 
in which nearly all (119) of the yeast protein kinases were 
overexpressed and assayed in a high-throughput manner on 
17 chip-immobilized protein and peptide substrates. How-
ever, such an extensive investigation has not been performed 
with human PTKs. 
  In this study, three different peptides previously charac-
terized with a small subset of PTK(s) were chosen for 
screening 81 human PTKs. The three peptides are derived 
from bona fide kinase substrate sequences and therefore rep-
resent putative in vivo targets. The CDK1 (Tyr15) or p34
cdc2 
(Tyr15) peptide was originally shown to be a suitable sub-
strate for four Src kinases: SRC, LYN, LCK, and FYN [5].  
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The IRS1 (Tyr983) peptide was chosen to represent a 
YMXM peptide. Peptides containing the YMXM motif were 
shown as effective substrates for receptor tyrosine kinases 
such as the insulin receptor [6], and also for non-receptor 
Tyr kinases [7]. Finally, the JAK1 (Tyr1023) peptide was 
shown to be a substrate for JAK3 [8]. In addition to the small 
peptides, the generic PTK substrates polyGT and polyGAT 
[9] were tested as controls of PTK activity.  
  The high-throughput TR-FRET platform, LANCE
® Ul-
tra, was used to measure enzyme activity, whereby the 
phosphopeptide product is detected by a highly sensitive 
anti-pTyr antibody labeled with europium chelate (Fig. 1). 
TR-FRET occurs between the chelate-labeled antibody and 
the dye-conjugated phosphopeptide upon excitation at 320 or 
34 nm. 
  Apart from providing valuable activity data for the 81 
PTKs, the profiling experiments demonstrated that the 
CDK1 and IRS1 peptides are highly selective for certain 
kinase sub-families, whereas the polyGT, polyGAT, and 
JAK1 peptides are promiscuous. Furthermore, novel activi-
ties for certain kinases, such as the Eph family, have been 
observed. 
MATERIALS AND METHODS 
Materials  
  All peptides are available from PerkinElmer. The CDK1, 
IRS1, and JAK1 peptides are labeled with the small fluores-
cent dye ULight
TM  via  conjugation to an N-terminal Cys 
residue, whereas the polyGAT and polyGT are labeled via 
conjugation to the amino terminus of the polypeptides. 
ULight-polyGT (4:1) and ULight-polyGAT (1:1:1) are 
polymers of amino acids (20-50 kDa) in which the amino 
acid ratios are as indicated. ULight-CDK1 (Tyr15) has the 
sequence: CAGAGKIGEGTYGVVYK; ULight-IRS1 
(Tyr983): CKKSRGDYMTMQIG; and ULight-JAK1 
(Tyr1023): CAGAGAIETDKEYYTVKD. The biotinylated 
pTyr-peptide has the sequence: biotin-AGAGIGEGT 
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from PerkinElmer. All kinases were recombinant (human 
origin) and purchased from Carna Biosciences.  
Fig. (1). LANCE Ultra TR-FRET technology for kinase assays.  
In these kinase assays, the binding of a Eu-labeled anti-phospho-
Tyr antibody (Eu-Ab) to the phosphorylated ULight-labeled sub-
strate brings donor and acceptor molecules into close proximity. 
After irradiation of the kinase reaction at 320 or 340 nm, the energy 
from the Eu donor is transferred to the ULight acceptor dye which, 
in turn, generates light at 665 nm. The intensity of the light emis-
sion is proportional to the level of ULight-substrate phosphoryla-
tion. 
 
Methods 
  The assays were performed in white, opaque Opti-
Plate
TM-384 microplates from PerkinElmer. The kinase reac-
tion buffer consisted of 50 mM HEPES pH 7.5, 1 mM 
EGTA, 10 mM MgCl2, 2 mM DTT and 0.01% Tween-20. 
EDTA, for stopping the reaction, and the detection antibody 
were prepared in LANCE Detection Buffer (PerkinElmer). 
All assay incubations were performed at 23°C and the mi-
croplates were sealed with TopSeal-A
TM film (PerkinElmer) 
during that time. The fluorescence signals were read using an 
excitation filter of 320 nm and an emission filter of 665 nm 
on an EnVision
® Multilabel Reader (PerkinElmer). The final 
assay volume was 20 L.  
  For determination of kinase concentrations to use in the 
assays that would not interfere in detection by the anti-
phospho-Tyr (PT66) antibody, 0 to 30 nM of each kinase 
was incubated with 50 nM of biotinylated pTyr-peptide in 
the presence of 200 M ATP for 2 h. The reaction was 
stopped by adding 10 mM EDTA and 50 nM ULight-
Streptavidin for 5 min. 2 nM Europium-anti-pTyr (PT66) 
antibody was added and incubated for another 1 h before 
reading the fluorescence.  
  For kinase profiling, the kinase was incubated with 50 
nM (ULight-CDK1 and ULight-JAK1) or 100 nM (ULight-
IRS1, ULight-polyGT and ULight-polyGAT) substrate in the 
presence or absence of 200 M ATP. The enzyme reaction 
proceeded for 2 h before stopping with 10 mM EDTA for 5 
min. 2 nM Europium-anti-pTyr antibody was added and in-
cubated for another 1 h before reading the fluorescence. The 
S/B ratio was calculated by dividing the fluorescence signal 
of the reaction with ATP by the signal from the reaction 
without ATP. All reactions were performed in duplicate and 
the average S/B ratio is reported. Almost all of the individual 
duplicate values for the S/B ratios were within 15% of the 
average values. 
RESULTS 
Determination of the Concentration of Kinase to Use in 
the Assays 
  The pTyr residues in the phosphopeptide products are 
detected by a highly specific anti-pTyr antibody. This anti-
body is highly promiscuous, since it is not specific for the 
peptide sequence surrounding the phosphorylated residue. In 
some cases, the kinase being analyzed contains Tyr auto-
phosphorylation sites. Therefore, the pTyr residues on the 
kinase can compete for the binding of the antibody to the 
phosphopeptide product. Hence, the kinase concentration has 
to be low enough so that it does not interfere with the signal 
generation. To determine the concentration of kinase to use 
in the assay, tests with the kinase and a pre-phosphorylated 
peptide were performed. Sufficient ATP was added to allow 
for protein autophosphorylation. The fluorescence signal 
generated by the phosphorylated peptide was plotted versus 
the concentration of enzyme and an example plot for JAK2 
kinase is illustrated in Fig. (2). In this case, 1 nM of enzyme 
was chosen for substrate profiling since the signal begins to 
 
Fig. (2). Example competition curve.  
The competition curve for JAK2 kinase was performed according 
to Materials and Methods. The fluorescence signal was plotted 
versus the concentration of enzyme and the highest concentration of 
enzyme providing minimal or no interference of signal was chosen 
for determination of activity versus the various ULight-substrates. 
In this case, 1 nM kinase was chosen. The error bars represent the 
standard deviation of triplicate measurements. Peptide Substrate Profiling of Tyrosine Kinases  Current Chemical Genomics, 2011, Volume 5    117 
Table 1.  Profiling Data for all Kinases. 
A 
Family   Kinase   Kinase concentration (nM)   polyGT   polyGAT   CDK1   IRS1   JAK1  
ABL   ABL   0.25  13.1  11.1  1.3  1.1  1.2 
ABL   ABL [T315I] (ABL1)   0.5  6.6  6.4  1.3  1.2  1.3 
ACK   ACK   20  27.3  27.2  4.8  1.5  2.0 
ABL   ARG   0.5  13.2  12.7  1.4  1.2  1.4 
SRC   BLK   0.5  16.5  7.8  9.6  1.1  2.6 
TEC   BMX   0.5  13.2  9.0  2.2  1.1  1.2 
FRK   BRK   3  17.4  3.0  1.4  1.3  1.1 
TEC   BTK   0.25  11.8  19.6  3.1  1.0  1.5 
CSK   CSK   20  10.4  20.3  1.7  1.3  3.9 
CSK   CTK   20  12.6  18.8  1.0  1.0  1.0 
FAK   FAK   3  20  13  1.0  1.0  1.0 
FES   FER   0.25  12.9  17.1  16.1  9.1  5.8 
FES   FES   1  17.1  19  10.3  7.2  4.0 
SRC   FGR   0.1  25.1  17.7  4.1  1.1  3.2 
FRK   FRK   0.5  20.8  22.9  1.3  1.1  2.2 
SRC   FYN   0.25  12.8  10.4  19.7  1.0  2.3 
SRC   HCK   0.25  21.3  13.2  12.8  1.2  5.1 
TEC    ITK    0.5  9.8 8.5 2.5 1.6  1.6 
JAK   JAK1   7  17.6  16.4  1.3  3.7  19.5 
JAK   JAK2   1  8.9  7.9  7.2  21.4  41.8 
JAK   JAK3   0.5  6.7  6.9  1.3  6.0  37.3 
SRC   LCK   0.5  10.4  16.5  6.1  1.0  1.7 
SRC    LYNa    0.5  15.6 8.9 14.3 1.1 7.4 
SRC   LYNb   1  18.6  13.2  24  1.2  18.3 
FAK   PYK2   0.25  15.5  7.7  2.3  1.1  1.3 
SRC   SRC   0.5  15.1  18.4  16.6  1.1  5.9 
FRK   SRM   0.5  18.3  20.1  8.0  1.3  2.0 
SYK   SYK   0.5  2.3  4.1  1.2  1.8  20 
TEC   TEC   0.5  25.4  15.4  2.2  1.0  1.8 
ACK   TNK1   1  9.3  15.2  2.4  1.6  1.2 
TEC   TXK   3  11  18.9  3.2  1.2  1.3 
JAK   TYK2   4  6.2  5.3  1.3  7.3  15.2 
SRC    YES    0.25  15.3 14 12.8 1.0  3.0 
SYK   ZAP70   4  11.1  15.3  1.1  1.1  6.7 
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B 
Family  Kinase  Kinase concentration (nM)  polyGT  polyGAT  CDK1  IRS1  JAK1 
ALK   ALK   4  9.8  7.2  2.6  16.8  3.9 
AXL   AXL   4  9.8  5.6  1.5  1.6  1.2 
DDR   DDR1    0.5  2.0 3.0 1.0 1.1  1.0 
DDR   DDR2    0.5  4.1 5.1 1.0 4.9  1.0 
EGFR   EGFR   0.5  1.7  5.0  1.8  2.5  19 
EGFR   EGFR [T790M]   0.5  18.1  10.8  1.1  1.2  3.9 
EPH   EphA1   0.5  24.1  11.4  3.1  1.2  1.2 
EPH   EphA2   0.25  12.3  7.1  2.1  1.8  3.9 
EPH   EphA3   0.5  17.4  8.0  4.4  3.5  3.8 
EPH   EphA4   0.5  12.6  11.3  6.7  2.4  6.4 
EPH   EphA5   1  18  21.9  19.2  7.6  21.2 
EPH   EphA6   0.5  14.2  15.5  1.2  1.1  1.3 
EPH   EphA7   0.5  22.7  11.1  1.4  1.3  1.5 
EPH   EphA8   0.25  16.4  7.8  3.1  1.6  5.6 
EPH   EphB1   0.5  25.1  7.9  14.1  8.4  10.6 
EPH   EphB2   0.25  27.9  13.2  13.1  3.8  5.7 
EPH   EphB3   0.1  29  11.2  8.3  2.3  4.0 
EPH    EphB4    0.5  13.7 4.0 12.6 4.8 12 
FGFR   FGFR1   0.5  2.9  5.0  1.6  13.5  30.8 
FGFR   FGFR2   0.25  7.8  11.6  1.6  15.5  33.2 
FGFR   FGFR3   0.25  16  10.7  1.4  8.1  27.6 
FGFR   FGFR4   3  9.2  5.6  1.2  3.4  20.8 
VEGFR   FLT1   0.25  22.2  15.4  1.1  1.9  10 
PDGFR   FLT3   0.1  20.8  13.2  3.6  4.5  25 
VEGFR   FLT4   0.25  6.9  6.5  1.8  11.4  36.9 
PDGFR   FMS (CSFR)   0.25  14.6  6.2  1.2  1.4  6.3 
EGFR   HER2    10  9.3 8.4 1.1 1.1  1.4 
EGFR   HER4 (ERBB4)   0.1  25.2  14.4  1.1  1.1  1.5 
INSR   IGF1R   0.25  21.8  14.6  3.1  15.2  12.8 
INSR   INSR   20  18.3  25.4  1.1  3.2  1.6 
INSR   IRR   0.5  21.6  9.1  2.4  15.6  12.7 
VEGFR   KDR    0.25  8.6 4.3 1.3 5.1  30.8 
PDGFR   KIT   2  13  21.7  1.0  1.0  3.3 
ALK   LTK   1  21.3  25.1  2.4  3.9  2.7 
AXL   MER   0.25  29.2  15.9  9.7  5.6  3.2 
MET   MET   0.5  17  13.2  4.1  4.5  19.7 
MUSK   MUSK   1  2.5  10.6  1.8  1.1  3.9 
PDGFR   PDGFRA  0.5  17.8  10.6  1.3  2.4  9.0 Peptide Substrate Profiling of Tyrosine Kinases  Current Chemical Genomics, 2011, Volume 5    119 
(Table 1). Contd….. 
Family  Kinase  Kinase concentration (nM)  polyGT  polyGAT  CDK1  IRS1  JAK1 
PDGFR   PDGFRB 0.25  11.2  12.5  1.6  2.0  3.0 
RET   RET   0.5  1.4  3.2  1.5  6.9  23.6 
MET   RON   0.25  27.7  25.7  1.3  4.4  4.9 
ROR    ROR1    20  3.4 1.5 0.9 1.0  1.0 
ROR    ROR2    20  4.2 1.4 1.0 0.9  1.0 
ROS   ROS   0.25  23.8  9  4.4  20.5  7.7 
TIE   TIE2   0.5  19.3  9.4  1.6  2.1  5.4 
TRK   TRKA (NTRK1)   0.5  16.3  17.5  5.5  11.8  15.1 
TRK    TRKB  (NTRK2)    0.5  22.9 26.3  7.0  11.1 17 
TRK   TRKC (NTRK3)   0.5  34.1  22.3  1.1  1.7  1.4 
AXL   TYRO3   0.25  21.5  9.1  4.7  4.8  2.1 
The S/B ratios for each kinase are tabulated. The results are separated based on kinase type: A) Cytoplasmic or non-receptor Tyr kinases and B) Receptor Tyr kinases. The classifica-
tion correlates with Robinson et al. [10] and Manning et al. [11]. 
decrease at 1 nM of enzyme. For all the kinases, the highest 
concentration of enzyme providing no significant interfer-
ence was chosen for determination of activity versus the 
various ULight-substrates. In a few cases, no interference 
was observed and 20 nM enzyme was used for the reaction. 
Kinase Profiling 
  81 human PTKs, plus two mutant kinases, Abl (T315I) 
and EGFR (T790M), were tested against the five substrates 
and the results are detailed in Table 1. The enzyme concen-
trations used varied from 0.1 to 20 nM, based on the poten-
tial interference of each enzyme in the phosphorylated pep-
tide detection. The substrate concentrations used were 50 nM 
or 100 nM depending on the substrate. The substrate concen-
trations were optimized to obtain acceptable signals and S/B 
ratios, since it is known that the anti-pTyr antibody can have 
different affinities for various peptides. If substrate concen-
trations are too high, then non-specific fluorescence is gener-
ated due to random proximity of the europium-anti-pTyr 
antibody and ULight dye. The concentration of ATP was 200 
μM, and is non-limiting in the kinase reaction. All five sub-
strates were assayed under very similar conditions for each 
enzyme. Therefore, the S/B value presented for each sub-
strate is a representation of the relative activity of the en-
zyme for each substrate. For example, ABL gave S/B values 
of 13 and 11 for polyGT and polyGAT, respectively. How-
ever, the other three substrates provided no signal at equiva-
lent enzyme concentration. 
  PolyGT gave an S/B ratio > 3 for 77 kinases. Interest-
ingly, SYK, DDR1, EGFR, FGFR1, MUSK, and RET did 
not show S/B ratios greater than 3, but some minimal activ-
ity between an S/B ratio of 1.4 and 2.9 was observed.  
  PolyGAT gave an S/B ratio > 3 for 81 kinases. Only 
ROR1 and ROR2 did not work with polyGAT, although S/B 
ratios of 3.4 and 4.2 were observed with polyGT for these 
two enzymes. 
  The CDK1 peptide was a very good substrate for two 
PTK families: Eph and Src. Only the EphA2, A6 and A7 
enzymes showed minimal activity out of the 12 EPH en-
zymes tested. All of the Src family kinases tested had sig-
nificant activity with the CDK1 peptide. 
  For the IRS1 peptide, 32 kinases, from 14 families, had 
an S/B ratio > 3. Only two of these families (6 kinases) were 
of the cytoplasmic or non-receptor type: Jak and Fes. 
  For the JAK1 peptide, 50 kinases, from 19 families, had 
an S/B ratio > 3. Some kinases were quite selective for the 
JAK1 peptide compared to the other four substrates, includ-
ing EGFR, FLT4, JAK3, KDR, RET, and SYK, where the 
S/B ratio was at least 3-fold higher than with the other four 
substrates. 
DISCUSSION  
  In the present work, almost all of the human PTKs were 
assayed with five peptidic substrates using a TR-FRET tech-
nology and purified recombinant enzymes. A unique pattern 
of human PTK selectivity was observed for the CDK1 and 
IRS1 peptides, whereas polyGT and polyGAT were sub-
strates for almost all of the kinases and JAK1 was active 
with over 60% of the kinases. In order to visually demon-
strate the selectivity of the peptide substrates, the activity of 
the PTKs towards the JAK1, CDK1, and IRS1 peptides is 
illustrated in dendrogram format in Fig. (3). In contrast to the 
JAK1 peptide, where almost all branches are highlighted 
with active kinases, the CDK1 and IRS1 peptides are only 
substrates for certain sub-families. 
  It was clearly observed that, indeed, polyGT and poly-
GAT can be considered as universal substrates for Tyr 
kinases and serve as good positive controls for PTK activity. 
On the other hand, using these non-specific substrates may 
be a disadvantage, because contaminating Tyr kinases may 
generate a signal that is not due to the kinase being studied. 
Polymeric peptides containing acidic amino acids and Tyr 
were originally described about 25 years ago [9]. To our 
knowledge, this is the first time that these polymeric peptides 
have been tested with such a wide variety of Tyr kinases.  120    Current Chemical Genomics, 2011, Volume 5  Blouin et al. 
Fig. (3). Dendrograms of PTK peptidic substrate selectivity.  
Kinases with S/B ratios greater than 3 are highlighted. The names 
of the kinases not tested were faded out. Dendrogram illustration 
reproduced courtesy of Cell Signaling Technology, Inc. 
(www.cellsignal.com). 
  Interestingly, the JAK1 peptide seemed to be promiscu-
ous for many Tyr kinases and it also represented a better 
substrate than polyGT and polyGAT in some cases. This 
broad activity may be related to the fact that it contains three 
acidic residues proximal to the Tyr residues: ETDKEYY. As 
for the polyGT and polyGAT polymers, the presence of 
acidic amino acids may cause the JAK1 peptide to be a non-
specific substrate for Tyr kinases. The lack of specificity 
towards the JAK1 peptide may also be a caution in other 
studies of peptide substrate specificity of PTKs. PTK bind-
ing to acidic peptides may be unrelated to the specificity of 
the kinase, but to a general structural preference of all the 
PTKs.  
  In the current study, all Src family kinases efficiently 
utilized the CDK1 peptide as a substrate and further demon-
strates the overall preference of the Src family for the CDK1 
peptide [5]. Interestingly, two of the three members of the 
Src-related Frk family, BRK and FRK, do not phosphorylate 
the CDK1 peptide, although both phosphorylated polyGT 
and polyGAT. Although the Frk family of kinases has se-
quence homology to the Src family, the catalytic specificities 
of the two families are different, further demonstrating the 
distinct nature of the Frk family of kinases [12]. 
  The ability of almost all Eph kinases to phosphorylate the 
CDK1 peptide was not predicted. A single report implicating 
EphA5 as a putative kinase phosphorylating CDK5 Tyr15 
has been published [13], and the preference of the Eph fam-
ily towards this substrate was not revealed by previous stud-
ies using synthetic peptides against the EphA3 and EphA4 
kinases [14,15]. However, the sequence around Tyr15 in 
CDK5, KIGEGTYGTVFK, is very similar to the CDK1 pep-
tide in this study: KIGEGTYGVVYK. This is the first time 
that the Eph family has been shown to directly phosphorylate 
the CDK-1 (Tyr-15) sequence. The Eph family of receptors 
is of particular importance due to their role in communica-
tion between adjacent cells and there are strong efforts to 
understand the complex signaling mechanisms of these 
PTKs [16]. 
  In the current study, 26 of the 32 kinases found to be  
active against the IRS1 peptide were receptor Tyr kinases, 
demonstrating that the IRS1 peptide is greatly favored by 
receptor Tyr kinases. Also, the IRS1 peptide was a very good 
substrate for JAK-1, 2, and 3 kinases, which are cytoplasmic 
kinases. The activity of the JAK kinases towards IRS1 has 
been previously reported [17]. Moreover, Jak family kinases 
show more sequence homology to receptor Tyr kinases than 
to cytoplasmic Tyr kinases. Indeed, the kinases acting on the 
IRS1 peptide tend to group entirely on the left side of the 
dendrogram shown in Fig. (3). 
  Overall, a high-throughput assay technology was used to 
profile five Tyr kinase substrates. The CDK1 and IRS1 pep-
tides demonstrated high selectivity for certain subfamilies, 
whereas the JAK1 peptide is promiscuous. Furthermore, this 
is the first publication showing the specificity of the Eph 
family towards the CDK1 (Tyr-15) sequence. Researchers 
may refer to this study to identify possible substrates for 
their kinase(s) of interest or to set-up kinase assays to further 
study the structure and function of the PTK(s). 
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ABBREVIATIONS 
polyGT =  polyGlu:Tyr(4:1) 
polyGAT = polyGlu:Ala:Tyr(1:1:1) 
pTyr =  phosphorylated  tyrosine 
PTK =  protein  tyrosine  kinase 
S/B =  signal  to  background 
TR-FRET  =  time-resolved fluorescence resonance energy 
transfer 
REFERENCES 
[1]  Gschwind A, Fischer OM, Ullrich A. The discovery of receptor 
tyrosine kinases: targets for cancer therapy. Nat Rev Cancer 2004; 
4(5): 361-70. 
[2]  Hubbard SR. Crystal structure of the activated insulin receptor 
tyrosine kinase in complex with peptide substrate and ATP analog. 
EMBO J 1997; 16(18): 5572-81. 
[3]  Songyang Z, Carraway KL, Eck MJ, et al. Catalytic specificity of 
protein-tyrosine kinases is critical for selective signalling. Nature 
1995; 373(6514): 536-9. 
[4]  Zhu H, Klemic JF, Chang S, et al. Analysis of yeast protein kinases 
using protein chips. Nat Genet 2000; 26(3): 283-9. 
[5]  Cheng HC, Nishio H, Hatase O, Ralph S, Wang JH. A synthetic 
peptide derived from p34
cdc2 is a specific and efficient substrate of 
src-family tyrosine kinases. J Biol Chem 1992; 267(13): 9248-56. 
[6]  Shoelson SE, Chatterjee S, Chaudhuri M, White MF. YMXM 
motifs of IRS-1 define substrate specificity of the insulin receptor 
kinase. Proc Natl Acad Sci USA 1992; 89(6): 2027-31. 
[7]  Garcia P, Shoelson SE, George ST, Hinds DA, Goldberg AR, 
Miller WT. Phosphorylation of synthetic peptides containing Tyr-
Met-X-Met motifs by nonreceptor tyrosine kinases in vitro. J Biol 
Chem 1993; 268(33): 25146-51. 
[8]  Wang R, Griffin PR, Small EC, Thompson JE. Mechanism of Janus 
kinase 3-catalyzed phosphorylation of a Janus kinase 1 activation 
loop peptide. Arch Biochem Biophys 2003; 410(1): 7-15. 
[9]  Braun S, Raymond WE, Racker E. Synthetic tyrosine polymers as 
substrates and inhibitors of tyrosine-specific protein kinases. J Biol 
Chem 1984; 259(4): 2051-4. 
[10]  Robinson DR, Wu YM, Lin SF. The protein tyrosine kinase family 
of the human genome. Oncogene 2000; 19(49): 5548-57. 
[11]  Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The 
protein kinase complement of the human genome. Science 2002; 
298(5600): 1912-34. 
[12]  Serfas MS, Tyner AL. Brk, Srm, Frk, and Src42A form a distinct 
family of intracellular Src-like tyrosine kinases. Oncol Res 2003; 
13(6-10): 409-19. 
[13]  Cheng Q, Sasaki Y, Shoji M, et al. Cdk5/p35 and Rho-kinase me-
diate ephrin-A5-induced signaling in retinal ganglion cells. Mol 
Cell Neurosci 2003; 24(3): 632-45. 
[14]  Warner N, Wybenga-Groot LE, Pawson T. Analysis of EphA4 
receptor tyrosine kinase substrate specificity using peptide-based 
arrays. FEBS J 2008; 275(10): 2561-73. 
[15]  Davis TL, Walker JR, Allali-Hassani A, Parker SA, Turk BE, Dhe-
Paganon S. Structural recognition of an optimized substrate for the 
ephrin family of receptor tyrosine kinases. FEBS J 2009; 276(16): 
4395-404. 
[16]  Pasquale EB. Eph-ephrin bidirectional signaling in physiology and 
disease. Cell 2008; 133(1): 38-52. 
[17]  Yin T, Keller SR, Quelle FW, et al. Interleukin-9 induces tyrosine 
phosphorylation of insulin receptor substrate-1 via JAK tyrosine 
kinases. J Biol Chem 1995; 270(35): 20497-502. 
 
 
 
Received: March 25, 2011  Revised: June 07, 2011  Accepted: June 11, 2011 
 
© Blouin et al.; Licensee Bentham Open. 
 
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the 
work is properly cited. 